Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by Wrywisdomon Jul 13, 2022 1:47pm
205 Views
Post# 34821382

ENTG Expands Primary Credit Facility with BMO Two More Years

ENTG Expands Primary Credit Facility with BMO Two More YearsFor those not aware, Entourage has extended and improved it's primary credit facility with Bank of Montreal for two more years, furthering it's relationship with one of Canada's most prestigious and established financial institutions. 

It also has extended it's agreements with secondary lenders beyond two years, with the flexibility to pay only interest at the discretion of Entourage.

Add to that revenues soaring every quarter (now more than 60 million dollars over the past 4 quarters), and they are firmly positioned to implement the entirety of their extraordinariy multifaceted strategy in the recreational and medical markets;  as well as furthering their synergies with Boston Beer, Mary's Medicinals, Fire and Flower, and much more. 

https://stockhouse.com/news/press-releases/2022/07/04/entourage-health-announces-amendments-to-its-credit-facilities-to-improve-debt

ENTG Revenues  should exceed expenses by the autumn as the growth and expansion phase winds down, and the revenues from expanded production tiers soar.

Simply a stellar opportunity here.
<< Previous
Bullboard Posts
Next >>